- Home
- SVRA vs CRON Comparison
SVRA vs CRON Comparison
Compare SVRA & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | CRON |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRA | CRON |
|---|---|---|
| Price | $5.60 | $2.61 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.4M |
| Earning Date | 03-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $132,357,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | N/A | $30.76 |
| P/E Ratio | ★ N/A | $27.65 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $1.89 | $1.60 |
| 52 Week High | $7.01 | $3.43 |
Technical Indicators
Market Signals| Indicator | SVRA | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 47.85 |
| Support Level | $5.10 | $2.57 |
| Resistance Level | $5.44 | $2.74 |
| Average True Range (ATR) | 0.35 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 52.33 | 54.05 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.